Search details
1.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32164906
2.
Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low-Risk, Locally Advanced Rectal Cancer (RaP Study/STAR-03).
Oncologist
; 23(8): 912-918, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29523646
3.
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
Gastric Cancer
; 20(5): 825-833, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28028664
4.
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.
Future Oncol
; 13(25): 2265-2275, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28976226
5.
[Sequential inhibition of angiogenesis in metastatic colorectal cancer: activity and efficacy of aflibercept]. / Inibizione sequenziale dell'angiogenesi nel carcinoma del colon-retto metastatico: attività ed efficacia di aflibercept in un caso clinico.
Recenti Prog Med
; 106(5): 239e-43e, 2015 May.
Article
in Italian
| MEDLINE | ID: mdl-25994542
6.
Translational challenges from the 2014 Gastrointestinal Cancers Symposium: toward a true tailored therapy through effective research.
Future Oncol
; 10(7): 1125-8, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24947252
7.
Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian study.
Invest New Drugs
; 30(5): 1978-83, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-21769636
8.
Totally implanted venous access devices implanted in the saphenous vein. Relation between the reservoir site and comfort/discomfort of the patients.
Ann Vasc Surg
; 26(8): 1127.e9-1127.e13, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22951064
9.
Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy.
Biomedicines
; 10(5)2022 Apr 30.
Article
in English
| MEDLINE | ID: mdl-35625772
10.
Out-of-pocket costs in gastrointestinal cancer patients: Lack of a perfectly framed problem contributing to financial toxicity.
Crit Rev Oncol Hematol
; 167: 103501, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34673219
11.
Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma?
J Geriatr Oncol
; 12(1): 163-167, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32653216
12.
An Italian study on treatment trends and outcomes of patients with stage III pancreatic adenocarcinoma in the gemcitabine era: is it time to change?
Anticancer Drugs
; 21(4): 459-64, 2010 Apr.
Article
in English
| MEDLINE | ID: mdl-20110805
13.
Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM 2802).
Clin Colorectal Cancer
; 19(2): 109-115, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32089455
14.
Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association.
ESMO Open
; 5(6): e001001, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33262200
15.
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical Oncologists.
Ecancermedicalscience
; 14: 1046, 2020.
Article
in English
| MEDLINE | ID: mdl-32565899
16.
Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials.
Cancers (Basel)
; 11(4)2019 Apr 24.
Article
in English
| MEDLINE | ID: mdl-31022922
17.
Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer.
ESMO Open
; 4(4): e000519, 2019.
Article
in English
| MEDLINE | ID: mdl-31555481
18.
Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition.
Clin Colorectal Cancer
; 18(2): 125-132.e2, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30846365
19.
Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancer.
Cancer Chemother Pharmacol
; 84(5): 1089-1096, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31493178
20.
Treatment of peritoneal carcinomatosis from colorectal cancer with cytoreductive surgery and perioperative intraperitoneal chemotherapy: state of the art and future prospects.
Surg Oncol
; 16 Suppl 1: S145-8, 2007 Dec.
Article
in English
| MEDLINE | ID: mdl-18023575